Psyon s.r.o.
- Address
- Cistovicka 249/11, Repy, 163 00 Prague, Czechia
Psyon s.r.o. - Psychedelic Medicine Research Center
Psyon s.r.o. is a specialized clinical research facility at the forefront of investigating psychedelic-assisted therapies for psychiatric and cardiovascular conditions. The center conducts advanced Phase III clinical trials examining novel therapeutic compounds combined with psychological support, representing cutting-edge approaches to treatment-resistant mental health disorders and chronic disease management.
- Treatment-resistant depression studies using psilocybin-based compounds with integrated psychological support
- Generalized anxiety disorder research evaluating single-dose psychedelic interventions
- Cardiovascular disease trials investigating atherosclerosis regression through psychedelic-assisted psychotherapy
The research center demonstrates unique expertise in psychedelic medicine, conducting both placebo-controlled and open-label extension studies. Their innovative portfolio includes examining the therapeutic potential of compounds like COMP360 and MM120 for mental health conditions, as well as pioneering investigations into psilocybin-assisted psychotherapy as an add-on therapy for stable ischemic heart disease, representing a novel intersection of psychiatric and cardiovascular medicine.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Cybin IRL Limited2active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Cybin IRL Limited2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Psyon s.r.o.
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Psilocybin (COMP360) in Adults with Treatment-Resistant Depression: A Phase III Randomized, Double-Blind, Controlled Trial | Compass Pathfinder Limited | Phase III | Not Recruiting | Feb 2024 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Psilocybine | 2 | Unknown | 2024-02-09 | 2024-10-14 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.